a Pharmaceutical Research Center , Mashhad University of Medical Sciences , Mashhad , Iran.
b Nanotechnology Research Center, School of Pharmacy , Mashhad University of Medical Sciences , Mashhad , Iran.
Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1095-1110. doi: 10.1080/21691401.2017.1376675. Epub 2017 Sep 28.
Cancer is a broad term for a class of prevalent diseases as one in three people develop cancer during their lifetime. Although, there are few success stories of cancer therapy, most of the existing medications do not lead to complete recovery. Because of the complexity of cancer, usually a single therapeutic approach is insufficient for the suppression of cancer growth and metastasis. Simultaneous loading and co-delivery of different agents with different physiochemical characteristics to the same tumors have been suggested for minimizing the dose of anticancer drugs and achieving the synergistic therapeutic impacts in cancers treatment. Intense work to develop nanotechnology-based systems as a suitable option for cancer treatment is currently underway. The purpose of this review is to provide an overview of the co-delivery systems based on polymeric nanoparticles including polymeric micelles, dendrimers, poly-d,l-lactide-co-glycolide, polyethylenimine, poly(l-lysine) and chitosan for efficacious cancer therapy.
癌症是一类常见疾病的统称,有三分之一的人在一生中会患上癌症。尽管癌症治疗有一些成功的案例,但大多数现有的药物并不能导致完全康复。由于癌症的复杂性,通常单一的治疗方法不足以抑制癌症的生长和转移。同时向同一肿瘤中加载和共递不同的具有不同物理化学特性的药物已被建议用于最小化抗癌药物的剂量并实现癌症治疗中的协同治疗效果。目前正在进行大量工作来开发基于纳米技术的系统作为癌症治疗的合适选择。本综述的目的是概述基于聚合物纳米粒子的共递药系统,包括聚合物胶束、树枝状大分子、聚(D,L-丙交酯-共-乙交酯)、聚乙烯亚胺、聚(L-赖氨酸)和壳聚糖,以实现有效的癌症治疗。
Artif Cells Nanomed Biotechnol. 2017-9-28
Eur J Pharm Biopharm. 2015-6
Eur J Pharm Sci. 2016-2-15
Adv Drug Deliv Rev. 2013-7-21
Biomater Sci. 2015-7
Adv Cancer Res. 2018-5-18
AAPS PharmSciTech. 2014-8
J Biomed Nanotechnol. 2015-5
Food Sci Nutr. 2025-8-19
Int J Mol Sci. 2025-7-11
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024
Int J Nanomedicine. 2024
Int J Mol Sci. 2024-6-27
Int J Nanomedicine. 2024
Int J Nanomedicine. 2024